2022 annual financial data
Fate Therapeutics, Inc. 2022 Operating margin
Fate Therapeutics, Inc. 2022 operating margin with verified reported values.
Direct answer
Operating margin was -320.23%.
Operating income was -308,386,000 USD and net income was -255,056,000 USD.
Operating cash flow was -248,208,000 USD.
Get free Fate Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 96,300,000 USD
- Operating income
- -308,386,000 USD
- Net income
- -255,056,000 USD
- Operating cash flow
- -248,208,000 USD